Genetic counselling and testing for susceptibility to breast, ovarian and colon cancer: Where are we today?

CMAJ. Canadian Medical Association Journal

Volumn 154, Issue 2, 1996, Pages 149-155

  Cole, David E C ^a   Gallinger, Steve ^b   McCready, David R ^b   Rosen, Barry ^b   Engel, June ^b   Malkin, David ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOSOMAL DOMINANT INHERITANCE; BREAST CANCER; CANCER SCREENING; CANCER SUSCEPTIBILITY; COLON CANCER; FAMILIAL CANCER; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; OVARY CANCER; PRACTICE GUIDELINE; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0030066282     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Knudson AG Jr: Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 1971; 68: 313-324
2. Goddard AD, Solomon EP: Genetic aspects of cancer. Adv Hum Genet 1993: 21: 321-376
3. Vogelstein B, Fearon EP, Hamilton SP et al: Genetic alterations during colorectal tumor development. N Engl J Med 1988; 319: 525-532
4. Friend S: The genetic basis of cancer. In Cossman J (ed): Molecular Genetics in Cancer Diagnosis, Elsevier, New York, 1990: 19-28
5. Schwechheimer K, Cavenee WK: Genetics of cancer predisposition and progression. Clin Invest Med 1993; 71: 488-502
6. Lynch HT, Lynch JF: Familial predisposition and cancer management. Contemp Oncol 1993; 3: 12-25
7. Eng C, Stratton M, Ponder B et al: Familial cancer syndromes. Lancet 1994; 343: 709-713
8. Birch JM, Hartley AL, Tricker KJ et al: Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res 1994; 54: 1298-1304
9. Li FP, Fraumeni JF Jr: Soft-tissue sarcomas, breast cancer, and other neoplasms: A familial syndrome? Ann Intern Med 1969; 71: 747-752
10. Malkin D, Li FP, Strong LC et al: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990; 250: 1233-1238
11. Srivastava S, Zou ZQ, Pirollo K et al: Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 1990; 348: 747-749
12. Li FP, Fraumeni JF Jr, Mulvihill JJ et al: A cancer family syndrome in twenty-four kindreds. Cancer Res 1988; 48: 5358-5362
13. Malkin D: p53 and the Li-Fraumeni syndrome. Biochim Biophys Acta 1994; 1198: 197-213
14. Malkin D, Jolly KW, Barbier N et al: Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N Engl J Med 1992; 326: 1309-1315
15. Toguchida J, Yamaguchi T, Dayton SH et al: Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. N Engl J Med 1992; 326: 1301-1308
16. Malkin D: Germline p53 gene mutations and cancer - Pandora's box or open sesame? J Natl Cancer Inst 1994; 86: 326-327
17. Narod SA, Feunteun J, Lynch HT et al: Familial breast-ovarian cancer locus on chromosome 17q12-23. Lancet 1991; 338: 82-83
18. Porter DE, Steel CM: Recent advances in the genetics of heritable breast cancer. Dis Markers 1993; 11: 11-21
19. Hall JM, Lee MK, Newman B et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990; 250: 1684-1689
20. Roberts L: Zeroing in on a breast cancer susceptibility gene Science 1993; 259: 622-625
21. Easton DF, Bishop DT, Ford D et al and the Breast Cancer Linkage Consortium: Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 1993; 52: 678-701
22. Shattuck-Eidens D, McClure M, Simard J et al: A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: implications for presymptomatic testing and screening. JAMA 1995; 273: 535-541
23. Easton DE, Ford D, Bishop DT: Breast Cancer Linkage Consortium (1993): Breast and ovarian cancer incidence in BRCA1 mutation carriers. Am J Hum Genet 1995; 56: 265-271
24. Struewing JP, Abeliovich D, Peretz T et al: The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. [letter] Nat Genet 1995; 11: 198-200
25. Rowell S, Newman B, Boyd J et al: Inherited predisposition to breast and ovarian cancer. [editorial] Am J Hum Genet 1994; 55: 861-865
26. King MC, Rowell S, Love SM: Inherited breast and ovarian cancer: What are the risks? What are the choices? JAMA 1993; 269: 1975-1980
27. Biesecker BB, Boehnke M, Calzone K et al: Genetic counselling for families with inherited susceptibility to breast and ovarian cancer. JAMA 1993; 269: 1970-1974
28. Miki Y, Swensen J, Shattuck-Eidens D et al: A strong candidate for the 17q-linked breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66-71
29. Futreal PA, Liu Q, Shattuck-Eidens D et al: BRCA1 mutations in primary breast and ovarian carcinomas. Science 1994; 266: 120-122
30. Tonin P, Serova O, Lenoir G et al: BRCA1 mutations in Ashkenazi Jewish women. [letter] Am J Hum Genet 1995; 57: 189
31. Wooster R, Neuhausen SL, Mangion J et al: Localization of the breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994; 265: 2088-2090
32. Narod S, Ford D, Devilee et al: Genetic heterogeneity of breast-ovarian cancer revisited. [letter] 1995; 57: 957-958
33. Ford D, Easton DP, Bishop DT et al and the Breast Cancer Linkage Consortium: Risks of cancer in BRCA1-mutation carriers. Lancet 1994; 343: 692-695
34. Hoskins KF, Stopfer JE, Calzone HA et al: Assessment and counselling for women with a family history of breast cancer: a guide for clinicians. JAMA 1995; 273: 577-585
35. National Cancer Institute of Canada: Canadian Cancer Statistics 1995, Toronto, 1995
36. Amos CI, Struewing JP: Genetic epidemiology of epithelial ovarian cancer. Cancer 1993, 71 (suppl 2): 566-572
37. Narod SA, Madlensky L, Bradley L et al: Hereditary and familial ovarian cancer in southern Ontario. Cancer 1994; 74: 2341-2346
38. Steichen-Gersdorf E, Gallion HH, Ford D et al: Familial site-specific ovarian cancer is linked to BRCA1 on 17q12-21. Am J Hum Genet 1994; 55: 870-875
39. Bourne TH, Campbell S, Reynolds KM et al: Screening for early lamilial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging. BMJ 1993; 306: 1025-1029
40. ACOG Committee Opinion: Committee on Gynecologic Practice. Genetic risk and screening techniques for epithelial ovarian cancer. Int J Gynecol Obstet 1993; 41: 321-323
41. Kerlikowske K, Brown JS, Grady DG: Should women with familial ovarian cancer undergo prophylactic oophorectomy? [review] Obstet Gynecol 1992; 80: 700-707
42. Tobacman JK, Greene MH, Tucker MA et al: Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families. Lancet 1982; 2: 795-797
43. Struewing JP, Watson P, Easton DF et al: Effectiveness of prophylactic oophorectomy in inherited breast/ovarian cancer. [abstract] Am J Hum Genet 1994; 55: A70
44. Society of Obstetricians and Gynaecologists of Canada Consensus Committee: Hormone replacement therapy and cancer. J Soc Obstet Gynaecol Can 1994; 16: 1665-1672
45. Lynch HT, Lanspa S, Smyrk T et al: Hereditary nonpolyposis colorectal cancer (Lynch syndromes I & II): genetics, pathology, natural history and cancer control, Part I. Cancer Genet Cytogenet 1991; 53: 143-160
46. Lynch HT, Smyrk TC, Watson P et al: Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 1993; 104: 1535-1549
47. Peltomaki P, Aaltonen LA, Sistonen P et al: Genetic mapping of a locus predisposing to human colorectal cancer. Science 1993; 260: 810-812
48. Nystrom-Lahti M, Parsons R, Sistonen P et al: Mismatch repair genes on chromosomes 2p and 3p account for a major share of hereditary nonpolyposis colorectal cancer families evaluable by linkage. Am J Hum Genet 1994; 55: 659-665
49. Nicolaides NC, Papadopoulos N, Liu B et al: Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994; 371: 75-80
50. Aaltonen LA, Peltomaki P, Leach FS et al: Clues to the pathogenesis of familial colorectal cancer. Science 1993; 260: 812-816
51. Thibodeau SN, Bren G, Scaid D: Microsatellite instability in cancer of the proximal colon. Science 1993; 260: 816-819
52. Vasen HFA, Mecklin JP, Meera Khan P et al: The international group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum 1991; 34: 424-425
53. Vasen HF, Mecklin JP, Watson P et al: Surveillance in hereditary nonpolyposis colorectal cancer: an international cooperative study of 165 Families. Dis Colon Rectum 1993; 36: 1-4
54. Watson P, Vasen HFA, Mecklin JP et al: The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer. Am J Med 1994; 96: 516-520
55. Narod S: Hereditary breast-ovarian cancer: How can we use the new DNA markers to improve patient management? [editorial] Clin Invest Med 1993; 16: 314-317
56. Sox HC Jr: Preventive health services in adults. N Engl J Med 1994; 330: 1589-1595